These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 6809316)
21. Opening blood-brain-barrier by intracarotid infusion of papaverine in treatment of malignant cerebral glioma. Xue H; Wang H; Kong L; Zhou H Chin Med J (Engl); 1998 Aug; 111(8):751-3. PubMed ID: 11245034 [TBL] [Abstract][Full Text] [Related]
22. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption. Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283 [TBL] [Abstract][Full Text] [Related]
23. Graded reversible opening of the rat blood-brain barrier by intracarotid infusion of sodium caprate. Preston E; Slinn J; Vinokourov I; Stanimirovic D J Neurosci Methods; 2008 Mar; 168(2):443-9. PubMed ID: 18155299 [TBL] [Abstract][Full Text] [Related]
24. Effect of osmotic blood-brain barrier disruption on methotrexate pharmacokinetics in the dog. Neuwelt EA; Frenkel EP; Rapoport S; Barnett P Neurosurgery; 1980 Jul; 7(1):36-43. PubMed ID: 6774280 [TBL] [Abstract][Full Text] [Related]
25. [Hemodynamic effects of an osmotic bolus for the reversible opening of the blood-brain barrier]. Hiesmayr M; Dirnberger H; Aloy A; Heimberger K; Horaczek A; Brandstätter B; Zimpfer M Schweiz Med Wochenschr; 1987 Mar; 117(12):450-4. PubMed ID: 3107120 [TBL] [Abstract][Full Text] [Related]
27. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery. Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413 [TBL] [Abstract][Full Text] [Related]
28. Re: Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma. Goldstein DA; Tessler HH Am J Ophthalmol; 2007 Dec; 144(6):976; author reply 976. PubMed ID: 18036877 [No Abstract] [Full Text] [Related]
29. Intra-arterial chemotherapy following blood-brain barrier disruption in a patient with malignant glioma. Hill SA; Neuwelt EA J Neurosurg Nurs; 1982 Apr; 14(2):94-7. PubMed ID: 6811704 [No Abstract] [Full Text] [Related]
30. Effect of duration of osmotherapy on blood-brain barrier disruption and regional cerebral edema after experimental stroke. Chen CH; Toung TJ; Sapirstein A; Bhardwaj A J Cereb Blood Flow Metab; 2006 Jul; 26(7):951-8. PubMed ID: 16306935 [TBL] [Abstract][Full Text] [Related]
31. Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma. Galor A; Ference SJ; Singh AD; Lee MS; Stevens GH; Perez VL; Peereboom DM Am J Ophthalmol; 2007 Jul; 144(1):45-49. PubMed ID: 17601426 [TBL] [Abstract][Full Text] [Related]
32. Is intra-arterial chemotherapy useful in high-grade gliomas? Basso U; Lonardi S; Brandes AA Expert Rev Anticancer Ther; 2002 Oct; 2(5):507-19. PubMed ID: 12382519 [TBL] [Abstract][Full Text] [Related]
33. Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours? Kemper EM; Boogerd W; Thuis I; Beijnen JH; van Tellingen O Cancer Treat Rev; 2004 Aug; 30(5):415-23. PubMed ID: 15245774 [TBL] [Abstract][Full Text] [Related]
34. Synergistic effect of cold mannitol and Na(+)/Ca(2+) exchange blocker on blood-brain barrier opening. Ikeda M; Bhattacharjee AK; Kondoh T; Nagashima T; Tamaki N Biochem Biophys Res Commun; 2002 Mar; 291(3):669-74. PubMed ID: 11855842 [TBL] [Abstract][Full Text] [Related]
35. Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption. Neuwelt EA; Diehl JT; Vu LH; Hill SA; Michael AJ; Frenkel EP Ann Intern Med; 1981 Apr; 94(4 pt 1):449-54. PubMed ID: 6782926 [TBL] [Abstract][Full Text] [Related]
36. Mannitol opening of the blood-brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin. Brown RC; Egleton RD; Davis TP Brain Res; 2004 Jul; 1014(1-2):221-7. PubMed ID: 15213006 [TBL] [Abstract][Full Text] [Related]
37. Blood-brain barrier disruption using mannitol: time course and electron microscopy studies. Cosolo WC; Martinello P; Louis WJ; Christophidis N Am J Physiol; 1989 Feb; 256(2 Pt 2):R443-7. PubMed ID: 2492773 [TBL] [Abstract][Full Text] [Related]
38. Enhanced disruption of the blood brain barrier by intracarotid mannitol injection during transient cerebral hypoperfusion in rabbits. Wang M; Etu J; Joshi S J Neurosurg Anesthesiol; 2007 Oct; 19(4):249-56. PubMed ID: 17893577 [TBL] [Abstract][Full Text] [Related]
39. Hyperosmolar blood-brain barrier disruption in baboons: an in vivo study using positron emission tomography and rubidium-82. Zünkeler B; Carson RE; Olson J; Blasberg RG; Girton M; Bacher J; Herscovitch P; Oldfield EH J Neurosurg; 1996 Mar; 84(3):494-502. PubMed ID: 8609564 [TBL] [Abstract][Full Text] [Related]